10. SAYFAYA BENZER SAYFALAR
Metabolik sendromda okside LDL düzeyleri - Sayfa 568. SUMMARY 48 OXIDIZED LDL LEVELS IN METABOLIC SYNDROME Metabolic syndrome is defined by criteria including risk factors for cardiovascular diseases, such as obesity (especially abdominal), dyslipidemia, hypertension and insulin resistance. Prevalance of the metabolic syndrome is being continously increased in Turkey as well as in the world due to obesity and sedentary life style. Before ...
Metabolik sendrom ve insülin direnci olan hastalarda ortalama trombosit hacmi düzeyi - Sayfa 5ABSTRACT
Purpose: Metabolic syndrome (MS), emerged in the basis of insulin resistance, is a collection of risk factors associated with an increased risk of cardiovascular disease in which there is a clinical picture containing proinflammatory and prothrombotic items. In our study, in patients with metabolic syndrome and insulin resistance, the association between the metabolic syndrome components...
Obez çocuklarda antropometrik ölçümler ile hipertansiyon, dislipidemi, hepatosteatoz arasındaki ilişki ve 25 (OH) Vitamin D''nin insülin direnci üzerine etkisi - Sayfa 9SUMMARY
The relationship Between Obesity and Hypertension, Dyslipidemia, Hepatosteatosis; the Effect of 25 (OH) Vitamin D on Insulin Resistance
Aim: To evaluate the relationship between anthropometric measurements included body mass index (BMI), body fat ratio (BFR), subscapular skin thickness (SST) others and obesity related complications as hypertension, serum lipid profile and insulin resista...
10. SAYFADAKI ANAHTAR KELIMELERstudylevelswerewithcholesterolgroup
10. SAYFA ICERIGI
SERUM ALANINE AMINOTRANSFERASE LEVELS AND THE FACTORS ASSOCIATED WİTH ALANINE AMINOTRANSFERASE LEVELS IN HEALTHY SUBJECTS
Aim: In recent years, many studies about the normal serum Alanine aminotransferase (ALT) levels have been reported. In these studies, it has been investigated whether the normal levels and the upper limits (UNL) of ALT are different from the currently used values and which potential factors are associated with ALT levels. The purpose of this study was to determine the UNL of serum ALT levels and the factors associated with serum ALT levels in appearently healthy subjects.
Methods: A total of 884 healthy subjects were included in the study. Serum ALT, fasting blood glucose and cholesterol levels were measured. Normal ranges and UNL for ALT were computed in the group of subjects with the lowest liver disease risk. Univariate and multivariate analyses were performed to determine the factors associated with the ALT levels.
Results: Serum ALT levels were independently associated with sex and body mass index whereas there were no association with age, fasting blood glucose and cholesterol levels. UNL for serum ALT levels in males and females were computed as 19,9 IU/L and 31,47 IU/L respectively.
Conclusion: Because serum ALT levels in healthy subjects is associated with sex, UNL for serum ALT levels in males and females should be defined seperately. In our study, UNL for ALT levels were determined to be lower than the current values. However, in order to make a firm desicion for the revision of UNL for ALT levels, we need further studies based on larger populations.